Cargando…
Metformin use and long-term risk of benign prostatic hyperplasia: a population-based cohort study
OBJECTIVE: To assess whether metformin use affects risk of benign prostatic hyperplasia (BPH) by comparing the risk of BPH in men with type 2 diabetes who initiated first-line treatment with either metformin or sulfonylurea monotherapy between 2000 or 2006 in Northern Denmark. In this period, sulfon...
Autores principales: | Nørgaard, Mette, Darvalics, Bianka, Thomsen, Reimar Wernich |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7757457/ https://www.ncbi.nlm.nih.gov/pubmed/33371039 http://dx.doi.org/10.1136/bmjopen-2020-041875 |
Ejemplares similares
-
Long-Term Risk of Surgery Following First Diagnosis of Benign Prostatic Hyperplasia in Middle-Aged Men
por: Rojanasarot, Sirikan, et al.
Publicado: (2022) -
Rezum Therapy for Benign Prostatic Hyperplasia: Dubai’s Initial Experience
por: Rowaiee, Rashed, et al.
Publicado: (2021) -
A Scoping Review of the Management of Benign Prostate Hyperplasia in Africa
por: Zubair, Abdulahi, et al.
Publicado: (2022) -
Monopolar Transurethral Resection of Prostate for Benign Prostatic Hyperplasia in Patients With and Without Preoperative Urinary Catheterization: A Prospective Comparative Study
por: Adhikari, Baikuntha, et al.
Publicado: (2021) -
Comorbidity and survival of Danish prostate cancer patients from 2000–2011: a population-based cohort study
por: Nguyen-Nielsen, Mary, et al.
Publicado: (2013)